These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2940462)

  • 41. Hepatitis B vaccination: how long does protection last?
    Laplanche A; Courouce AM; Jungers P; Benhamou E; Crosnier J
    Lancet; 1984 Oct; 2(8407):866. PubMed ID: 6148592
    [No Abstract]   [Full Text] [Related]  

  • 42. Recombinant DNA hepatitis B vaccination in teenagers: effect of a booster at 5 1/2 years.
    Milne A; Waldon J
    J Infect Dis; 1992 Oct; 166(4):942. PubMed ID: 1388197
    [No Abstract]   [Full Text] [Related]  

  • 43. Boosting properties of recombinant DNA hepatitis B vaccine.
    Ambrosch F; Kremsner P; Wiedermann G; Frisch-Niggemeyer W; Kunz C; Andre FE; Safary A
    Lancet; 1986 May; 1(8489):1101. PubMed ID: 2871370
    [No Abstract]   [Full Text] [Related]  

  • 44. When should at-risk patients with thalassaemia be boosted with hepatitis B vaccine?
    Matsaniotis N; Kattamis C; Laskari S; Tzeti M; Markosoglou D
    Lancet; 1987 Jun; 1(8545):1321. PubMed ID: 2884443
    [No Abstract]   [Full Text] [Related]  

  • 45. [Preliminary evaluation of hepatitis B vaccination in dialysis patients].
    Arakawa Y; Kusumi Y; Sudo H; Sudo H; Miyamoto M
    Nihon Shokakibyo Gakkai Zasshi; 1985 Nov; 82(11):2856. PubMed ID: 2935658
    [No Abstract]   [Full Text] [Related]  

  • 46. Uveitis after hepatitis B vaccination.
    Fried M; Conen D; Conzelmann M; Steinemann E
    Lancet; 1987 Sep; 2(8559):631-2. PubMed ID: 2887922
    [No Abstract]   [Full Text] [Related]  

  • 47. More about response to hepatitis B vaccine in hemodialysis patients.
    Vagelli G; Calabrese G; Mazzotta A; Pratesi G; Gonella M
    Nephron; 1988; 49(2):171. PubMed ID: 2967921
    [No Abstract]   [Full Text] [Related]  

  • 48. Vaccination in hemodialysis patients.
    Schwebke J; Mujais S
    Int J Artif Organs; 1989 Aug; 12(8):481-4. PubMed ID: 2680997
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term follow-up of Hepatitis B Surface antibody levels in subjects receiving universal Hepatitis B vaccination in infancy in an area of hyperendemicity: correlation between radioimmunoassay and enzyme immunoassay.
    Wang CW; Wang LC; Chang MH; Ni YH; Chen HL; Hsu HY; Chen DS
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1442-7. PubMed ID: 16339069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of long-term efficacy of hepatitis B vaccine.
    Ayerbe MC; Pérez-Rivilla A;
    Eur J Epidemiol; 2001; 17(2):150-6. PubMed ID: 11599689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients.
    Schwabe RF; Engelmann H; Hess S; Fricke H
    Clin Exp Immunol; 1999 Jul; 117(1):153-8. PubMed ID: 10403929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A mathematical model predicting anti-hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B.
    Honorati MC; Palareti A; Dolzani P; Busachi CA; Rizzoli R; Facchini A
    Clin Exp Immunol; 1999 Apr; 116(1):121-6. PubMed ID: 10209515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Duration of hepatitis B antibody response in children immunised with hepatitis B and compulsory vaccines.
    Li Volti S; Giammanco-Bilancia G; Giammanco G; Mollica F
    Eur J Epidemiol; 1995 Apr; 11(2):217-9. PubMed ID: 7672079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity of hepatitis B vaccine (HEVAC B) in children with advanced renal failure.
    Pillion G; Chiesa M; Maisin A; Schlegel N; Loirat C
    Pediatr Nephrol; 1990 Nov; 4(6):627-9. PubMed ID: 2088465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hepatitis B vaccination in dialysis patients: reversibility of defective immune response by simultaneous administration of interleukin 2].
    Zeitz M
    Z Gastroenterol; 1990 Mar; 28(3):179-80. PubMed ID: 2140478
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatitis B vaccine in dialysis patients.
    Courouce AM; Jungers P; Benhamou E; Laplanche A; Crosnier J
    N Engl J Med; 1984 Dec; 311(23):1515-6. PubMed ID: 6239101
    [No Abstract]   [Full Text] [Related]  

  • 57. [Comparison of Merck and Pasteur plasma-derived hepatitis B vaccines in 2 populations of hemodialysis patients].
    Volterrani A; Di Giandomenico G; Di Giandomenico FW
    Minerva Med; 1990; 81(1-2):23-5. PubMed ID: 2138259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Preventive hepatitis B vaccination].
    Glathe H; Dürkop J; Rasch G
    Z Arztl Fortbild (Jena); 1990; 84(8):381-3. PubMed ID: 2143042
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term results of hepatitis B vaccination in patients on dialysis.
    Benhamou E; Courouce AM; Laplanche A; Jungers P; Tron JF; Crosnier J
    N Engl J Med; 1986 Jun; 314(26):1710-1. PubMed ID: 2940462
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.